These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 227959)
1. Target-effector interaction in the natural killer cell system. IV. Modulation by cyclic nucleotides. Roder JC; Klein M J Immunol; 1979 Dec; 123(6):2785-90. PubMed ID: 227959 [TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2-induced changes in the phenotype, morphology, and lytic activity of IL-2-activated natural killer cells. Linnemeyer PA; Pollack SB J Immunol; 1993 May; 150(9):3747-54. PubMed ID: 8386202 [TBL] [Abstract][Full Text] [Related]
3. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice. Brunda MJ; Taramelli D; Holden HT; Varesio L J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831 [TBL] [Abstract][Full Text] [Related]
4. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF). Wright SC; Bonavida B J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909 [TBL] [Abstract][Full Text] [Related]
5. Purine metabolites suppress proliferation of human NK cells through a lineage-specific purine receptor. Miller JS; Cervenka T; Lund J; Okazaki IJ; Moss J J Immunol; 1999 Jun; 162(12):7376-82. PubMed ID: 10358189 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates. Bonavida B; Lebow LT; Bradley TP J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675 [TBL] [Abstract][Full Text] [Related]
7. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF). Wright SC; Bonavida B J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908 [TBL] [Abstract][Full Text] [Related]
8. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes. Holmes KV; Welsh RM; Haspel MV J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198 [TBL] [Abstract][Full Text] [Related]
9. An exoglycosidase-sensitive triggering site on NK cells which is coupled to transmethylation of membrane phospholipids. Kiyohara T; Dennis JW; Boegman RJ; Roder JC J Immunol; 1985 Jul; 135(1):659-64. PubMed ID: 3923114 [TBL] [Abstract][Full Text] [Related]
10. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors. Colmenares C; Lopez C J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891 [TBL] [Abstract][Full Text] [Related]
11. Target-effector cell interaction in the natural killer cell system. V. Energy requirements, membrane integrity, and the possible involvement of lysosomal enzymes. Roder JC; Argov S; Klein M; Petersson C; Kiessling R; Andersson K; Hansson M Immunology; 1980 May; 40(1):107-16. PubMed ID: 6968289 [TBL] [Abstract][Full Text] [Related]
12. Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations. Ghayur T; Seemayer TA; Lapp WS Transplantation; 1987 Aug; 44(2):254-60. PubMed ID: 3498241 [TBL] [Abstract][Full Text] [Related]
13. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes. Grönberg A; Ferm MT; Ng J; Reynolds CW; Ortaldo JR J Immunol; 1988 Jun; 140(12):4397-402. PubMed ID: 3131433 [TBL] [Abstract][Full Text] [Related]
14. Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells. Roozemond RC; Bonavida B J Immunol; 1985 Apr; 134(4):2209-14. PubMed ID: 3855929 [TBL] [Abstract][Full Text] [Related]
15. Differences in target cell DNA fragmentation induced by mouse cytotoxic T lymphocytes and natural killer cells. Duke RC; Cohen JJ; Chervenak R J Immunol; 1986 Sep; 137(5):1442-7. PubMed ID: 2943792 [TBL] [Abstract][Full Text] [Related]
16. Window of vulnerability of vaccinia virus-infected cells to natural killer (NK) cell-mediated cytolysis correlates with enhanced NK cell triggering and is concomitant with a decrease in H-2 class I antigen expression. Brutkiewicz RR; Klaus SJ; Welsh RM Nat Immun; 1992; 11(4):203-14. PubMed ID: 1421956 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event. Steele TA; Brahmi Z J Immunol; 1988 Nov; 141(9):3164-9. PubMed ID: 3262683 [TBL] [Abstract][Full Text] [Related]
18. Signal transduction during human natural killer cell activation: inositol phosphate generation and regulation by cyclic AMP. Windebank KP; Abraham RT; Powis G; Olsen RA; Barna TJ; Leibson PJ J Immunol; 1988 Dec; 141(11):3951-7. PubMed ID: 2846696 [TBL] [Abstract][Full Text] [Related]
19. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents. Marcoz P; Prigent AF; Lagarde M; Nemoz G Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905 [TBL] [Abstract][Full Text] [Related]
20. Natural killer activity in cloned cytotoxic T lymphocytes: regulation by interleukin 2, interferon, and specific antigen. Brooks CG; Holscher M; Urdal D J Immunol; 1985 Aug; 135(2):1145-52. PubMed ID: 2409140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]